Literature DB >> 35895118

CT, MRI, and radiomics studies of liver metastasis histopathological growth patterns: an up-to-date review.

Shenglin Li1,2,3,4, Zhengxiao Li1,2,3,4, Xiaoyu Huang1,2,3,4, Peng Zhang5, Juan Deng1,2,3,4, Xianwang Liu1,2,3,4, Caiqiang Xue1,2,3,4, Wenjuan Zhang1,2,3,4, Junlin Zhou6,7,8,9.   

Abstract

The histopathological growth patterns (HGPs) of liver metastases (LMs) are independently associated with the long-term prognosis of the primary tumor, with different HGPs predicting different patient outcomes and clinical treatment decisions. Non-invasive imaging biomarkers for stratification of HGPs are beneficial for treatment monitoring, evaluation of efficacy, and prognosis prediction of LMs. This review describes the state of research regarding computed tomography (CT), magnetic resonance imaging (MRI), and radiomics imaging biomarkers for LM-HGPs; discusses the advantages of CT, MRI, and radiomics for classification of LM-HGPs; and provides a reference for the stratification of LM-HGPs. Finally, the difficulties and deficiencies of CT, MRI, and radiomics in LM-HGP research are summarized along with the proposed directions for future research.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CT; Histopathological growth patterns; Liver metastasis; MRI; Radiomics

Mesh：

Year:  2022        PMID： 35895118     DOI： 10.1007/s00261-022-03616-z

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  43 in total

Review 1.  Liver metastases.

Authors:  Diamantis I Tsilimigras; Pnina Brodt; Pierre-Alain Clavien; Ruth J Muschel; Michael I D'Angelica; Itaru Endo; Rowan W Parks; Majella Doyle; Eduardo de Santibañes; Timothy M Pawlik
Journal:  Nat Rev Dis Primers       Date:  2021-04-15       Impact factor: 52.329

Review 2.  Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy.

Authors:  Pieter-Jan van Dam; Sofie Daelemans; Elizabeth Ross; Yannick Waumans; Steven Van Laere; Emily Latacz; Roanne Van Steen; Christel De Pooter; Mark Kockx; Luc Dirix; Peter B Vermeulen
Journal:  Semin Cancer Biol       Date:  2018-01-31       Impact factor: 15.707

3.  Histological growth patterns of colorectal cancer liver metastases: a strong prognostic marker associated with invasive patterns of the primary tumor and p53 alteration.

Authors:  Hiroyuki Abe; Yoichi Yasunaga; Sho Yamazawa; Yudai Nakai; Wataru Gonoi; Yujiro Nishioka; Koji Murono; Kazuhito Sasaki; Junichi Arita; Kazushige Kawai; Hiroaki Nozawa; Kiyoshi Hasegawa; Soichiro Ishihara; Tetsuo Ushiku
Journal:  Hum Pathol       Date:  2022-03-03       Impact factor: 3.466

4.  Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns.

Authors:  Nouredin Messaoudi; David Henault; David Stephen; Isabelle Cousineau; Eve Simoneau; Zhixia Rong; Richard Létourneau; Marylène Plasse; Michel Dagenais; André Roy; Réal Lapointe; Franck Vandenbroucke-Menu; Rastislav Kunda; Dirk Ysebaert; Geneviève Soucy; John Stagg; Peter Vermeulen; Simon Turcotte
Journal:  Br J Cancer       Date:  2022-01-03       Impact factor: 9.075

5.  Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment.

Authors:  Florian E Buisman; Daniele Giardiello; Nancy E Kemeny; Ewout W Steyerberg; Diederik J Höppener; Boris Galjart; Pieter M H Nierop; Vinod P Balachandran; Andrea Cercek; Jeffrey A Drebin; Mithat Gönen; William R Jarnagin; T P Kingham; Peter B Vermeulen; Alice C Wei; Dirk J Grünhagen; Cornelis Verhoef; Micheal I D'Angelica; Bas Groot Koerkamp
Journal:  Eur J Cancer       Date:  2022-04-14       Impact factor: 10.002

Review 6.  Targeting metastasis.

Authors:  Patricia S Steeg
Journal:  Nat Rev Cancer       Date:  2016-04       Impact factor: 60.716

Review 7.  The immunological and metabolic landscape in primary and metastatic liver cancer.

Authors:  Xin Li; Pierluigi Ramadori; Dominik Pfister; Marco Seehawer; Lars Zender; Mathias Heikenwalder
Journal:  Nat Rev Cancer       Date:  2021-07-29       Impact factor: 60.716

8.  Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases.

Authors:  Pieter Mh Nierop; Diederik J Höppener; Florian E Buisman; Eric P van der Stok; Boris Galjart; Vinod P Balachandran; William R Jarnagin; T Peter Kingham; Jinru Shia; Murielle Mauer; Bernard Nordlinger; Catherine Julié; Bas Groot Koerkamp; Michail Doukas; Peter B Vermeulen; Dirk J Grünhagen; Michael I D'Angelica; Cornelis Verhoef
Journal:  J Pathol Clin Res       Date:  2021-09-04

Review 9.  The multifaceted role of the microenvironment in liver metastasis: biology and clinical implications.

Authors:  Gert G Van den Eynden; Ali W Majeed; Martin Illemann; Peter B Vermeulen; Nigel C Bird; Gunilla Høyer-Hansen; Rikke Løvendahl Eefsen; Andrew R Reynolds; Pnina Brodt
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

10.  International consensus guidelines for scoring the histopathological growth patterns of liver metastasis.

Authors:  Pieter-Jan van Dam; Eric P van der Stok; Laure-Anne Teuwen; Gert G Van den Eynden; Martin Illemann; Sophia Frentzas; Ali W Majeed; Rikke L Eefsen; Robert R J Coebergh van den Braak; Anthoula Lazaris; Maria Celia Fernandez; Boris Galjart; Ole Didrik Laerum; Roni Rayes; Dirk J Grünhagen; Michelle Van de Paer; Yves Sucaet; Hardeep Singh Mudhar; Michael Schvimer; Hanna Nyström; Mark Kockx; Nigel C Bird; Fernando Vidal-Vanaclocha; Peter Metrakos; Eve Simoneau; Cornelis Verhoef; Luc Y Dirix; Steven Van Laere; Zu-Hua Gao; Pnina Brodt; Andrew R Reynolds; Peter B Vermeulen
Journal:  Br J Cancer       Date:  2017-10-05       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.